2699P Comprehensive molecular profiling of perivascular epithelioid cell neoplasms

Justine Gantzer; Xiaofan Lu; Céline Charon‐Barra; Charles Vinson; Noëlle Weingertner; Damien Plassard; S. Vicaire; François Le Loarer; Maud Toulmonde; Mehdi Brahmi; Axel Le Cesne; Alice Hervieu; François Bertucci; Thomas Ryckewaert; Thibaud Valentin; Florence Duffaud; Emmanuelle Bompas; Jean Yves Blay; Jenny Kurtz; Gabriel G. Malouf

doi:10.1016/j.annonc.2025.08.3310

Article2022

PEC-PRO: A new prognostic score from a series of 93 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.

Justine Gantzer, Maud Toulmonde, François Séverac, Ali N. Chamseddine, Céline Charon‐Barra, Agathe Bourgmayer, François Bertucci, Thomas Ryckewaert, Thibaud Valentin, Nelly Firmin, L. Chaigneau, Emmanuelle Bompas, Philippe Follana, Laurence Bozec Lemoal, Florence Duffaud, Patrick Schöffski, Jean Yves Blay, Mehdi Brahmi, Gabriel G. Malouf

Article2024

PEC‐PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent

Justine Gantzer, Maud Toulmonde, François Séverac, Ali N. Chamseddine, Céline Charon‐Barra, Charles Vinson, Alice Hervieu, Agathe Bourgmayer, François Bertucci, Thomas Ryckewaert, Thibaud Valentin, Nelly Firmin, L. Chaigneau, Emmanuelle Bompas, Philippe Follana, Pauline Soibinet‐Oudot, Laurence Bozec, François Le Loarer, Noëlle Weingertner, Christine Chevreau, Florence Duffaud, Jean Yves Blay,

Preprint2023

Data from Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Roberta Sanfilippo, Robin L. Jones, Jean Yves Blay, Axel Le Cesne, Salvatore Provenzano, Γεώργιος Αντωνίου, Olivier Mir, Giovanni Fucá, Elena Fumagalli, Rossella Bertulli, Silvia Stacchiotti, Mehdi Brahmi, Federica Grosso, Armelle Dufresne, Nadia Hindi, Marta Sbaraglia, Alessandro Gronchi, Paola Collini, Angelo Paolo Dei Tos, Paolo G. Casali

Preprint2023

Data from Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Roberta Sanfilippo, Robin L. Jones, Jean Yves Blay, Axel Le Cesne, Salvatore Provenzano, Γεώργιος Αντωνίου, Olivier Mir, Giovanni Fucá, Elena Fumagalli, Rossella Bertulli, Silvia Stacchiotti, Mehdi Brahmi, Federica Grosso, Armelle Dufresne, Nadia Hindi, Marta Sbaraglia, Alessandro Gronchi, Paola Collini, Angelo Paolo Dei Tos, Paolo G. Casali

Preprint2023

Supplementary Figure S2 from Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Roberta Sanfilippo, Robin L. Jones, Jean Yves Blay, Axel Le Cesne, Salvatore Provenzano, Γεώργιος Αντωνίου, Olivier Mir, Giovanni Fucá, Elena Fumagalli, Rossella Bertulli, Silvia Stacchiotti, Mehdi Brahmi, Federica Grosso, Armelle Dufresne, Nadia Hindi, Marta Sbaraglia, Alessandro Gronchi, Paola Collini, Angelo Paolo Dei Tos, Paolo G. Casali

2699P Comprehensive molecular profiling of perivascular epithelioid cell neoplasms

Discussion(0)

Related publications

PEC-PRO: A new prognostic score from a series of 93 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.

PEC‐PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent

Data from Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Data from Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Supplementary Figure S2 from Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)